A clinically proven. Cognition enhancer
|
|
- Sophia Charles
- 5 years ago
- Views:
Transcription
1 R A clinically proven Cognition enhancer
2 What is Memory loss? Memory is the ability of the brain to store, retain and subsequently recall information. In the recent decades, it has become one of the principal pillars of a new branch of science, cognitive neuroscience. Cognition refers to the processes through which information coming from the senses is transformed, reduced, elaborated, recovered, and used. The term information, used here, refers simply to sensory input from the environment that informs us about something that is happening there. Cognitive processes are thus the mental processes involved in knowing about the world; as such, they are important in perception, attention, thinking, problem solving and memory. Causes of Memory loss Aging Alzheimer's disease Neurodegenerative illness ead trauma or injury ysteria often accompanied by confusion Seizures General anesthetics Alcoholism Stroke or transient ischemic attack (TIA) Transient global amnesia Drugs such as barbiturates or benzodiazepines Electroconvulsive therapy (especially if prolonged) Temporal lobe brain surgery Brain masses (caused by tumors or infection) erpes encephalitis ther brain infections Depression Amnesia and Dementia are the two major classes of memory disorders seen in clinical populations. Amnesia refers to a specific, acquired difficulty in learning new information and/or remembering information from the past. Dementia is a more broadly defined cognitive disorder, of which amnesia is the primary feature. Alzheimer's disease (AD) is the world's leading cause of dementia and the most prevalent Neurodegenerative disease (NDD) % of dementia is estimated to be caused by this disease AD affects the mental abilities including memory, language and cognition. AD usually arises in late middle age or the elderly but there is a rare familial subtype that occurs earlier. Global incidence Worldwide, there is a new case of dementia every seven seconds. More than 24.3 million people are currently estimated to have dementia, and 4.6 million new cases are diagnosed each year. Dementia is expected to double between 2001 and 2040 in developed nations, it is forecast to increase by more than 300 percent in India and China. Ref: Ferri et al., Global prevalence of dementia: a Delphi consensus study. The Lancet. 2005: 366: pp Prevalence of Alzheimer's disease: 4.5 million cases in America, it is expected to increase to million cases in America by 2050 (Alzheimer's Association, 2004) 1
3 erbal approach to Memory loss Bacopa monnieri (Linn.) Pennell. English name : Bacopa Local name : Brahmi Family : Scrophulariaceae Part used : Entire plant What Ayurveda says about Brahmi? Bacopa monnieri is one of the most honored medicinal plant in Ayurveda and has been used traditionally since 3000 years.. ye eefïe.. ces³ee.. mce=efleòeoe.. (Yee. Òe.) (Good for brain, enhances memory).. ye eefïe.. yegef Òeoe.. cesee³egjeqivepeveveer.. mce=efleoe.. (efve. j.) (Improves intelligence, enhances memory).. ye eefïe.. ces³ee.. (ie. efve.) (Brain tonic).. ye eefïe.. mce=efleòeoe.. (ce. ee. efve. ce. efje.) (Enhances memory) R What is? R (patent pending) is a clinically proven (both in elderly and children) enriched standardized phytochemical composition derived from the plant Bacopa monnieri, which is well known in Ayurveda as a brain tonic. Natural Remedies R is launched after an extensive research work by. R has scientific backup of multiple in vitro, animal and clinical studies to substantiate its beneficial effects as a cognition enhancer and in the management of age related neurodegenerative disorders. 2
4 Clinical Trials in a Nut Shell Approved Protocol Investigator selection Approval process Patient recruitment and participation Data filed and registration obtained Presentation and publication of report Statistical Analysis Data entered and reviewed Clinical evidence - Safety of Phase I Clinical trial of BacoMind in elderly volunteers Subjects Place Dose & Duration Results 15 elderly volunteers (age group between years) Ahmedabad, India BacoMind 300 mg once a day for first 14 days and 450 mg for further 14 days BacoMind was found to be safe and tolerable. No side effects were reported in any of the treated volunteers. The physical, hematological and biochemical parameters were within the normal limits. Phase I Clinical trial of BacoMind in healthy adult volunteers Subjects Place Dose & Duration Results 23 healthy adult volunteers (age group between years) Bangalore, India BacoMind 300 mg once a day for first 15 days and 450 mg for further 15 days BacoMind was found to be safe and tolerable. Though minor gastrointestinal side effects were reported in 4 out of 23 volunteers, the physical, hematological, biochemical and electrocardiographic parameters were within the normal limits. Ref: Pravina K et al., Safety evaluation of BacoMind in healthy volunteers: A phase I study, Phytomedicine, 2007, 14: pp
5 Clinical studies of in older persons Efficacy and Tolerability of BacoMind on memory improvement in older persons. A double blind placebo controlled study Subjects Place Dose & Duration 59 elderly individuals (age group between years) Ahmedabad, India BacoMind 450 mg once a day for 24 weeks BacoMind showed a significant reduction in time required for cancellation test from baseline value Improvement in Attention week 12th week 24th week BacoMind Placebo BacoMind showed a significant improvement in Delayed recall component of list learning test Improvement in Memory 50 BacoMind helped in better visual retention memory as observed in visual retention test Improvement in visual retention Memory 0 0 week 12th week 24th week BacoMind Placebo Baseline BacoMind Placebo BacoMind showed a significant improvement in Delayed recall component of paired associates dissimilar test at 24th week Improvement in Memory Baseline BacoMind Placebo 4
6 Clinical studies of in children Efficacy study of BacoMind on memory improvement in Children requiring Individual Education Programme [IEP] Subjects Place Dose & Duration Result 24 children (aged between 4-18 years) Mumbai, India BacoMind 225 mg once a day for 4 months BacoMind treatment revealed a significant improvement in various memory related tasks in the children requiring IEP Improvement in memory test scores in BacoMind treated children requiring IEP Baseline Recognition Visual reproduction Verbal retention of dissimilar word pairs Verbal retention of similar word pairs Repeating sentences Repeating words Digit span Mental control rientation Information % improvement 5
7 Pre-Clinical evidence : In vivo studies Nootropic activity of BacoMind using passive shock avoidance test in mice Animals Test material Dose & duration Results 42 albino Swiss mice (20-22 g) of either sex BacoMind 40, 60 and 80 mg/kg for 7 days. BacoMind showed significant decrease in the latency to reach Shock free zone [SFZ] and in the number of mistakes in 15 min at all the tested doses when compared to the vehicle control. BacoMind administered at the dose of 60 mg/kg in scopolamine treated mice showed significant decrease in latency to reach SFZ and in the number of mistakes in 15 min as compared to the scopolamine control Vehicle control (10 ml/kg) Scopolamine (0.3 mg/kg) BacoMind (60 mg/kg) + Scopolamine (0.3 mg/kg) Animals were placed on the electric grid (20 V with AC current of 5 ma); the latency to reach SFZ and the mistakes (descents) the animal made in 15 min were recorded Nootropic activity of BacoMind using object recognition test in rats Animals 42 albino Wistar rats ( g) of either sex Test material Dose & duration Results BacoMind 27, 40 and 54 mg/kg for 7 days. BacoMind showed a significant increase in the discrimination index at all the tested doses when compared to the vehicle control. BacoMind administered at the dose of 40 mg/kg in scopolamine treated rats showed significant increase in the discrimination index as compared to the scopolamine control Vehicle control (10 ml/kg) Scopolamine (0.3 mg/kg) BacoMind (40 mg/kg)+ Scopolamine(0.3 mg/kg) The time spent by the animals for exploration (directing nose at a distance < 2 cm to the object or touching it with nose) of the familiar (F) and new (N) objects were recorded and Discrimination Index (D) was calculated as follows; Discrimination index [D] = N-F / N+F. 6
8 Nootropic activity of BacoMind using elevated plus maze test in mice Animals Test material Dose & duration Results 42 albino Swiss mice (20-22 g) of either sex BacoMind 40, 60 and 80 mg/kg for 7 days. A significant decrease in the inflexion ratio was noticed in the scopolamine treated group as compared to the vehicle control. BacoMind administered at the dose of 60 mg/kg in scopolamine treated mice showed significant increase in the inflexion ratio as compared to the scopolamine control Vehicle control (10 ml/kg) Scopolamine (0.3 mg/kg) BacoMind (60 mg/kg)+ Scopolamine(0.3 mg/kg) Transfer latency (TL) [the time taken by the mouse to move into the enclosed arm of the elevated plus maze] was measured and expressed as inflexion ration [initial TL-Later TL / Later TL] In Vitro studies on BacoMind BacoMind exhibited butyrylcholinesterase activity BacoMind has up to 60 percent more affinity to 5-T6receptors than Bacoside A. BacoMind inhibited lipoxygenase (LX) activity BacoMind showed antioxidant potential in the following models DPP radical scavenging assay ABTS radical scavenging assay RAC assay Safety of A phase I clinical study on BacoMind has indicated that it is safe and well tolerated in healthy adults and elderly volunteers. No side effects were reported in any of the treated volunteers. The physical, hematological and biochemical parameters were within the normal limits. Pravina K et al., Safety evaluation of BacoMind in healthy volunteers: A phase I study, Phytomedicine, 2007, 14: pp ral administration of BacoMind (500mg/kg body weight) for 90 days did not cause any mortality and significant adverse effects in rats. LD of BacoMind was found to be 2400mg/kg in rats*. In addition, no 50 mutagenicity could be detected in the Ame's test. *Joshua Allan J et al., Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague Dawley rats, Food and Chemical Toxicology (In Press). 7
9 ow Bacopa works? With reference to cognition enhancement Agonist activation of 6 5-T-1A receptors Inhibits Lipoxygenase 7 activity Modulation of acetylcholine release, choline acetyl transferase and muscarinic receptor 8 & 9 Inhibits butyrylcholinesterase 10 activity May Attenuate PKC activity since it reduces norepinephrine 1 & 6 levels in ippocampus May act thro'5-t6 2 receptors Reduces amyloid levels 3 in the Brain 4 Anti-oxidant activity Agonist activation of 5 5-T-1A receptors 1. Birnbaum SG et al., Science.2004 :306 (5697): pp Natural Remedies, In house report 3. olcomb LA et al., J Alzheimers Dis :9(3): pp Bhattacharya SK et al., Phytother Res 2000 b:14: pp Parker K and Medora R. Annual meeting of the American Society of Pharmacognosy on July 24 at regon State University in Corvallis, regon. 6. Singh K and Dhawan BN. Indian J Pharmacol 1997:29: pp Dhanasekaran M et al., Phytother Res. 2007: 29 [Epub ahead of print] 8. Bhattacharya SK et al., Molecular aspects of Asian medicine. New York: PJD Publications: 2000: pp Agarwal A. A comparative study of psychotropic drugs and biofeedback therapy in the prevention and management of psychosomatic disorder. Thesis: Institute of Medical Sciences, Banaras indu University; Pravina K et al., Phytomedicine, 2007, 14: pp Publications & Presentations on Publications Pravina K et al., Safety evaluation of BacoMind in healthy volunteers: A phase I study, Phytomedicine, 2007, 14: pp Kasture SB et al., Nootropic activity of BacoMind, an enriched phytochemical composition from Bacopa monnieri, Journal of Natural Remedies, 2007: 7 (1): pp Joshua Allan J et al., Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague Dawley rats, Food and Chemical Toxicology (In Press). Dipanwita Dutta Deb et al., In vitro safety evaluation and Anticlastogenic Effect of BacoMind on uman Lymphocytes. Journal of Biomedical and Environmental Sciences (Communicated). Deepak M et al., Quantitative determination of the major saponins mixture bacoside A in Bacopa monnieri by PLC. Phytochem Anal. 2005: 16: pp Deepak M and Amit A. The need for establishing identities of bacoside A and B, the putative major bioactive saponins of Indian medicinal plant Bacopa monnieri. Phytomedicine. 2004: 11: pp Presentations th Proceedings of the International Conference on Toxicology, Toxicogenomics and ccupational ealth (ICTT) & 26 Annual Meeting of Society of Toxicology (STX), Gwalior, Joshua Allan J et al., Safety evaluation of BacoMind A standardized extract of Bacopa monnieri in Sprague Dawley rats. P Joshua Allan J et al., Toxicity studies on BacoMind : A standardized phytochemical composition from Bacopa Monnieri: PP: 97. th Proceedings of the International Conference on Advances in Drug Discovery Research 11 ISCBC 2007 Lucknow. Barbhaiya C et al., A double blind placebo controlled study of BacoMind on cognition enhancement in elderly volunteers. P: Kasture SB et al., Effect of BacoMind, an enriched phytochemical composition from Bacopa monnieri, on learning and memory in rats and mice. PP: Pravina K et al., Evaluation of safety and tolerability of BacoMind in healthy volunteers. PP: Dipanwita Dutta Deb et al., Antigenotoxic and Anticlastogenic Effect of BacoMind on uman Lymphocytes. International Conference on Biomarkers in ealth and Environmental Management Coimbatore. 8
10 Phytochemistry BacoMind is an enriched phytochemical composition with true claims on the optimum levels of nine bioactive constituents Bacoside A 3 Bacopaside II Jujubogenin isomer of bacopasaponin C Bacopasaponin C Bacopaside I Bacosine C 2 S C3 Apigenin Luteolin β-sitosterol-d-glucoside 9
11 C3 Standardization of PLC and PTLC Chromatograms 0.4 Luteolin Bacoside A Bacopaside II 0.2 S Bacopaside I Jujubogenin isomer of bacopasaponin C Apigenin Bacopasaponin C C β-sitosterol-d-glucoside
12 Why? Availability BacoMind is clinically proven. Chemical standardization involving assay of 9 different bioactive compounds by PLC*. Biological standardization using, Lipoxygenase inhibition, Butyryl cholinesterase inhibition, ABTS radical scavenging, RAC and DPP assays for each batch*. Supported with phytochemical reference standards (with spectroscopic and chromatographic characterization). Manufactured in a GMP and IS certified manufacturing facility. The Product is Kosher certified. BacoMind is available as a free flowing powder with a unique chemical and biological quality control support. Recommended Dose* For adult mg /day/adult for 12 weeks. For children - 225mg /day/child for 12 weeks. BacoMind is recommended for incorporation in dietary / nutraceutical formulations intended for improving memory and age related neuro-degenerative disorders. Corporate ffice : Ashwathlakshmi Mansion, No. 364, II Floor, 16th Main, 4th 'T' Block, Jayanagar, Bangalore INDIA Ph : / Fax : / R & D Centre : Plot No. 5B, Veerasandra Industrial Area, 19th K. M. Stone, osur Road, Electronic City Post, Bangalore INDIA Ph : / 98 / 97 / 96 Fax : / madhu@naturalremedy.com Website : Disclaimer : These statements have not been evaluated by the Food and Drug Administration or any other regulatory body. This product is not intended to diagnose, treat, cure or prevent any disease. "Natural Remedies calls to readers' attention that some of the products, protocols and uses of the product/s described herein are or may be subject to various restrictions or limitations because of patents, exclusive or nonexclusive licenses, confidentiality agreements and other intellectual property or equivalent rights. Readers are advised to make an early and thorough investigation and inquiry into any product, protocol or use in which they may be interested, to see if any such rights might be applicable".
Safety evaluation of BacoMind TM in healthy volunteers: A phase I study
Phytomedicine 14 (2007) 301 308 www.elsevier.de/phymed Safety evaluation of BacoMind TM in healthy volunteers: A phase I study K. Pravina a, K.R. Ravindra c, K.S. Goudar a, D.R. Vinod a, A.J. Joshua a,
More informationextracts from India The World Health Organization (WHO) estimates 4 billion people use herbal medicine.
World Class Botanicals extracts from India Presented by: Madhu.K Team Leader International Business Remedies Pvt Lts Bangalore madhu@naturalremedy.com, www.naturalremedycom Remedies Solutions for Healthy
More informationAnurag Agarwal Chief Operating Officer Natural Remedies Pvt Ltd. Bangalore
I ndian Herbals Global opportunities Anurag Agarwal Chief Operating Officer Natural Remedies Pvt Ltd. Bangalore Time : Date : 28 th June, 2007 16.00 pm to 17.30 pm Venue: Hotel Marriot, Hyderabad WORLD
More information7. NOOTROPIC AND ANTIOXIDANT ACTIVITY. 7.1 Introduction
268 7. NOOTROPIC AND ANTIOXIDANT ACTIVITY 7.1 Introduction Alzheimer s disease is a neurodegenerative disorder, which according to World Health Organization (WHO) affects 22 million people world wide,
More informationIMPROVES SCHOLASTIC PERFORMANCE OF CHILDREN REDUCES DAY-TO-DAY WORK STRESS IN ADULTS
IMPROVES SCHOLASTIC PERFORMANCE OF CHILDREN REDUCES DAY-TO-DAY WORK STRESS IN ADULTS IMPROVES CHILD S ABILITY TO STORE OR REPRODUCE INFORMATION MEMTONE INGREDIENTS ACTIVE COMPONENT ACTIONS JATAMANSI Nardostachysin
More informationBR-16A (Mentat), A Herbal Preparation, Improves Learning and Memory Performance in Mice
[Indian Drugs (1993): (30), 3, 97] BR-16A (Mentat), A Herbal Preparation, Improves Learning and Memory Performance in Mice Kulkarni, S.K. and Anita Verma Department of Pharmaceutical Sciences, Punjab University,
More informationEvidence for Nootropic Effect of BR-16A (Mentat), A Herbal Psychotropic Preparation, in Mice
[Indian Journal of Physiology and Pharmacology (1992): 36 (1), 29] Evidence for Nootropic Effect of BR-16A (), A Herbal Psychotropic Preparation, in Mice Kulkarni, S.K. and Anita Verma Department of Pharmaceutical
More informationPharmacological Profile of BR-16A (Mentat)
[Probe (1995): (XXXIV), 2, 124-139] Pharmacological Profile of BR-16A (Mentat) Kulkarni, S.K. and Verma, A. Department of Pharmaceutical Sciences, Panjab University, Chandigarh, India. ABSTRACT The present
More informationDetermination of Saponin Glycosides in Bacopa monnieri by Reversed Phase High Performance Liquid Chromatography
riginal Article Determination of Saponin Glycosides in Bacopa monnieri by Reversed Phase High Performance Liquid Chromatography Watoo Phrompittayarat 1,2, Sakchai Wittaya-areekul 3, Kanchalee Jetiyanon
More informationLearning & memory enhancing activity of Aerial parts of Ervatamia coronaria (L)
Page2501 Indo American Journal of Pharmaceutical Research, 2013 ISSN NO: 2231-6876 Journal home page: http:///index.php/en/ INDO AMERICAN JOURNAL OF PHARMACEUTICAL RESEARCH Learning & memory enhancing
More informationABELMOSCHUS MOSCHATUS
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article MEMORY STRENGTHENING ACTIVITY ON SEEDS OF ABELMOSCHUS MOSCHATUS S. Nandhini, R. Vadivu* and
More informationNootropic Activity of Saponins obtained from Tinospora Cordifolia Stem in Scopolamine induced Amnesia
Research Article Nootropic Activity of Saponins obtained from Tinospora Cordifolia Stem in Scopolamine induced Amnesia *Hemant D. Une, Momin A. Ejaj, Vinod A. Tarde Pharmacology Department, Y. B. Chavan
More informationEffect of BR-16A on Alpha-2 Adrenergic, Dopamine Autoreceptor and Dopamine Postsynaptic Receptor Functioning
[Indian Journal of Pharmacology (1994): 26, 292-295] Effect of BR-16A on Alpha-2 Adrenergic, Dopamine Autoreceptor and Dopamine Postsynaptic Receptor Functioning Chittaranjan Andrade, Department of Psychopharmacology,
More informationINTRODUCTION. PHYTOTHERAPY RESEARCH Phytother. Res. (2008) ( DOI: /ptr.2537
PHYTOTHERAPY RESEARCH Phytother. Res. (2008) Published online in Wiley InterScience NOOTROPIC EFFECTS OF BACOPA MONNIERA 1 (www.interscience.wiley.com).2537 Examining the Nootropic Effects of a special
More informationInternational Journal of Pharma and Bio Sciences V1(2)2010 PLUMBAGO ZEYLANICA ROOTS: A POTENTIAL SOURCE FOR IMPROVEMENT OF LEARNING AND MEMORY
VINEET MITTAL* 1, SHARMA S. K. 2, PAWAN JALWAL 1,ANIL HOODA 1 AND J.MOR 1 1 Shri Baba mastnath Institute of Pharmaceutical Sciences & Research, Asthal Bohr, Rohtak-124021 2 Professor, Deptt. of Pharmaceutical
More informationThe Better Health News2
February, 2009 Volume 4, Issue 1 The Better Health News2 Special Interest Articles: Curry and Disease Name That Food Nutrition and Disease Diet, Supplmentation and Dementia Elemental Diet and Crohn s Disease
More informationBrahmi and Cognition: Nature s Brainpower Enhancer By Wendy Weissner
Brahmi and Cognition: Nature s Brainpower Enhancer By Wendy Weissner Is learning and absorbing new information difficult for you? Do you ever feel that a fact or memory is on the tip of your toungue, but
More informationInternational Journal of Pharma and Bio Sciences ROLE OF ANGIOTENSIN ANTAGONISTS IN MEMORY ENHANCEMENT S.INDUMATHY* 1, S.KAVIMANI 2 AND K.V.
International Journal of Pharma and Bio Sciences ROLE OF ANGIOTENSIN ANTAGONISTS IN MEMORY ENHANCEMENT S.INDUMATHY* 1, S.KAVIMANI 2 AND K.V.RAMAN 3 1 Department of, Mother Theresa Postgraduate and Research
More informationFINAL REPORT STUDY TITLE. EVALUATION OF APHRODISIAC ACTIVITY OF VigRx IN MALE ALBINO WISTAR RATS. Report No.: R401.
FINAL REPORT STUDY TITLE EVALUATION OF APHRODISIAC ACTIVITY OF IN MALE ALBINO WISTAR RATS STUDY DIRECTOR Dr. Amit A, Ph.D. SPONSOR AIBMR Life Sciences, Inc. 4117, South Meridian, Puyallup, WA 98373 CONTENTS
More informationAlzheimer Disease Research Center
UPMC Montefiore, 4 West 200 Lothrop Street Pittsburgh, PA 15213-2582 412-692-2700 Fax: 412-692-2710 Dear Friends: Thank you for your inquiry about the (ADRC). Attached is an application which asks for
More informationEvaluation Of Anticonvulsant Activity Of Ethanolic Extract Of Murraya Koenigii Leaves In Wistar Rats
Evaluation Of Anticonvulsant Activity Of Ethanolic Extract Of Murraya Koenigii Leaves In Wistar Rats Dr. Pallavi M Kamath Dept. of Pharmacology JJM Medical College Davanagere, Karnataka Introduction Epilepsy
More informationChapter 10. Summary and Conclusions
Chapter 10 Summary and Conclusions Nardostachys jatamansi 70% ethanolic extract (NJE) was prepared and its metabolite profile was assessed using phytochemical screening for the quantification of polyphenols,
More informationSession 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients
18 th Presidential Commission for the Study of Bioethical Issues August 20, 2014 Washington, DC Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients Freddie Ann Hoffman,
More informationAnti-convulsant activity of different extracts of Centella asiatica and Bacopa monnieri in animals
Vol. 2/1 (2002) 33-33 41 JOURNAL OF NATURAL REMEDIES Anti-convulsant activity of different extracts of Centella asiatica and Bacopa monnieri in animals S. Sudha 1, S. Kumaresan 1, A. Amit 2, J. David 1,
More informationeidisine is easily added to any food- or beverage product and gives a temporary boost of cognitive functions, including memory
eidisine TM is a natural healthy active food ingredient that makes you smarter eidisine is easily added to any food- or beverage product and gives a temporary boost of cognitive functions, including memory
More informationCholinergic influence on memory stages: A study on scopolamine amnesic mice
Research Article Cholinergic influence on memory stages: A study on scopolamine amnesic mice Rahul Agrawal, Ethika Tyagi, Gunjan Saxena, Chandishwar Nath 1 ABSTRACT Division of Pharmacology, 1 Division
More informationMODIFICATION OF NOOTROPIC ACTIVITY OF ALBIZZIA LEBBECK SAPONINS BY SEROTONERGIC AGENTS. Suvarna P.Ingale*, Sanjay B, Kasture #
MODIFICATION OF NOOTROPIC ACTIVITY OF ALBIZZIA LEBBECK SAPONINS BY SEROTONERGIC AGENTS Suvarna P.Ingale*, Sanjay B, Kasture # *Assistant Professor, Dept. of Pharmacology, Indira College of Pharmacy, New
More informationA Stronger Start to Every Workout
XSURGE A Stronger Start to Every Workout It happens all the time: athletes get into a great workout or training routine and suddenly, their performance starts to decline. Fatigue sets in. Muscle soreness
More informationANXIOLYTIC PROFILE OF A POLYHERBAL DRUG MENTAT
Int. J. Pharm. Med. & Bio. Sc. 2013 Amitabh A Kumar and Reddy Kiran K P, 2013 Research Paper ISSN 2278 5221 www.ijpmbs.com Vol. 2, No. 4, October 2013 2013 IJPMBS. All Rights Reserved ANXIOLYTIC PROFILE
More informationepilepticus (SE) or trauma. Between this injury and the emergence of recurrent
Introduction Epilepsy is one of the oldest medical disorders known. The word epilepsy derived from the Greek word epilamhanein, meaning to be seized or to be overwhelmed by surprise. Epilepsy is one of
More informationT H E B E T T E R H E A L T H N E W S
Dr. Paul G. Varnas & WholeHealthAmerica.com present V O L U M E 7, I S S U E 2 T H E B E T T E R H E A L T H N E W S F E B R U A R Y, 2 0 1 0 D E M E N T I A A N D E X E R C I S E L E T S H E A R I T F
More informationJournal of Global Trends in Pharmaceutical Sciences
An Elsevier Indexed Journal ISSN-2230-7346 Journal of Global Trends in Pharmaceutical Sciences EVALUATION OF THE NOOTROPIC EFFECT OF ACORUS CALAMUS IN EXPERIMENTAL ANIMALS M. Madhavi*, G.Gopi Reddy Department
More informationRisk Assessment of Naturals
Risk Assessment of Naturals Adip Roy Safety & Environmental Assurance Centre, Unilever R&D, 64 Main Road, Whitefield, Bangalore 560066 Naturals Traditional health care systems (Ayurveda & TCM) Time tested
More informationMARKER BASED STANDARDISATION OF PLANT BASED FORMULATIONS CONTAINING BRAHMI USING BACOSIDE A BY HPTLC
Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 6, Issue 1, 2014 Research Article MARKER BASED STANDARDISATION OF PLANT BASED FORMULATIONS CONTAINING
More information2 5.1 Roots of Withania somnifera Structure of Withanolide G 99. A- C 22 -O- β-d-glucoside) Structure of Withaferin A 100
LIST OF FIGURES 1 1.1 Standardization and Quality Evaluation of Herbal Drugs 33 2 5.1 Roots of Withania somnifera 97 3 5.2 Structure of Withanolide G 99 4 5.3 Structure of Sitoindosides IX (withaferin-a-c
More informationbe a potential therapeutic agent for Alzheimer s type of dementia. These results give the promising effects of the selected drugs and the bioactive
11 be a potential therapeutic agent for Alzheimer s type of dementia. These results give the promising effects of the selected drugs and the bioactive molecule for the treatment and management of memory
More informationCorporate Presentation August 6, 2015
Corporate Presentation August 6, 2015 Creating the Next Generation of CNS Drugs Forward-Looking Statement This presentation contains forward-looking statements. These statements relate to future events
More informationVolume 23 Issue
Volume 23 Issue 3 2011 A publication of the National Herbalists Association of Australia A clinical study to evaluate the efficacy and safety of Bacopa caplets in memory and learning ability: a double
More informationTerm Paper: Ginkgo Biloba s Influence on Memory and Cognition
1 Term Paper: Ginkgo Biloba s Influence on Memory and Cognition 2 Introduction The aging process is inevitable. Over time our bodies and the functions they provide start to decline in many aspects. Cognitive
More informationVol-3, Issue-4, Suppl-2, Nov 2012 ISSN: Shah et al PHARMA SCIENCE MONITOR
PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES FORMULATION DEVELOPMENT AND EVALUATION OF UNIT MOULDED POLYHERBAL JELLY USEFUL IN MEMORY ENHANCEMENT Bhoomika Shah, Bhavesh Nayak
More informationDEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease
What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There
More informationNootropic Studies of Ethanolic Extract of Mimosa pudica Linn. in Albino Wistar Rats
Original Article Nootropic Studies of Ethanolic Extract of Mimosa pudica Linn. in Albino Wistar Rats Sibi P Ittiyavirah * & Delphia P George Pharmacology, University College of Pharmacy, Cheruvandoor P.O,
More informationAnxiolytic effects of Elaeocarpus sphaericus fruits on the elevated plus-maze model of anxiety in mice
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.2, No.3, pp 1781-1786, July-Sept 2010 Anxiolytic effects of Elaeocarpus sphaericus fruits on the elevated plus-maze
More informationThe volunteers were divided into three parts to study the effect of BESEB.
Brahmi is an important drug known for its memory enhancing property. In Ayurveda this drug is described as a Rasayana drug. The Rasayana therapy (rejuvenating therapy) aims specially at the promotion of
More informationIntroduction. Cultivation
Sabinsa Corporation is proud to announce that ForsLean, our unique product for promoting lean body mass, is now available to dietary supplement manufacturers. Introduction ForsLean is an extract prepared
More informationCSE511 Brain & Memory Modeling Lect 22,24,25: Memory Systems
CSE511 Brain & Memory Modeling Lect 22,24,25: Memory Systems Compare Chap 31 of Purves et al., 5e Chap 24 of Bear et al., 3e Larry Wittie Computer Science, StonyBrook University http://www.cs.sunysb.edu/~cse511
More informationMemory Disorders. 1. Episodic: memory for time and places. 2. Semantic: memory for facts and knowledge (language, numbers, etc).
I. Types of memory: A. Declarative memory: Memory Disorders 1. Episodic: memory for time and places. 2. Semantic: memory for facts and knowledge (language, numbers, etc). B. Procedural memory: - examples:
More informationInvolvement of GABA in Nootropic and Anxiolytic Activity of Saponins of Albizzia lebbeck Leaves
Involvement of GABA in Nootropic and Anxiolytic Activity of Saponins of Albizzia lebbeck Leaves K.N. Gujar Sinhgad College of Pharmacy Sinhgad Tech. Education Soc. Pune 411 041 India S.B. Kasture Natural
More informationBR-16A Protects Against ECS-Induced Anterograde Amnesia
[Biological Psychiatry (1994): 36, 478-481] BR-16A Protects Against ECS-Induced Anterograde Amnesia Jerry Joseph, Venkataraman, B.V., Naga Rani, M.A. and Chittaranjan Andrade Department of Pharmacology,
More informationGiven the present state of
YOUR BRAIN HEALTH Brain disorders are on the rise, for your brain is not something you can afford to ignore. Diminished brain health influences every aspect of your life from mood and health, to relationships
More informationSOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS
SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS Dr Paraskevi Sakka Neurologist - Psychiatrist Athens Association of Alzheimer s Disease and Related Disorders Neurodegenerative
More informationFurther Studies on the Effect of an Indigenous Compound Rasayana Drug on Physical and Mental Disability in Aged Persons
[J. Res. Ind. Med. Yoga and Homoeo, (1979): 14, 2, 45] Further Studies on the Effect of an Indigenous Compound Rasayana Drug on Physical and Mental Disability in Aged Persons Singh, R.H. Reader in Kayachikitsa,
More informationIn-Service Education. workbook 3. by Hartman Publishing, Inc. second edition
In-Service Education workbook 3 second edition by Hartman Publishing, Inc. Alzheimer s Disease Dignity Diabetes Restraints and Restraint Alternatives Abuse and Neglect Death and Dying Managing Stress Perf
More informationTHE COMPLETE CBD GUIDE
THE COMPLETE CBD GUIDE WHAT IS CBD (CANNABIDIOL)? 2 WHERE DOES CBD COME FROM? 3 HOW DOES CBD WORK IN THE BODY? 4 HOW MUCH CBD DO I TAKE? 5-6 CBD OIL VS. HEMP OIL 7 CBD NOT THC 8 THE BENEFITS OF CBD 9 PETS
More informationRanking Nutritional Supplements Botanical Medicine Primary
Your Monthly Update Dear Colleague Welcome to the October newsletter from Pure Bio Ltd. Did you know...? The UK organic market grew by 30% and averaged sales of 7million a week in 2005! Our topic for this
More informationPharmacophore 2014, Vol. 5 (5), USA CODEN: PHARM7 ISSN Pharmacophore. (An International Research Journal)
Pharmacophore 2014, Vol. 5 (5), 676-683 USA CODEN: PHARM7 ISSN 2229-5402 Pharmacophore (An International Research Journal) Available online at http://www.pharmacophorejournal.com/ Original Research Paper
More informationMigraine: Developing Drugs for Acute Treatment Guidance for Industry
Migraine: Developing Drugs for Acute Treatment Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) February 2018
More informationDetermination and Quantification of Bacoside A From Bacopa monnieri (L) By High Performance Thin Layer Chromatography
Available online on www.ijppr.com International Journal of Pharmacognosy and Phytochemical Research 2015; 7(5); 1060-1065 Review Article ISSN: 0975-4873 Determination and Quantification of Bacoside A From
More informationT1: RESOURCES TO ADDRESS THE NEEDS OF PERSONS WITH DEMENTIA AND THEIR CAREGIVERS 2014 GOVERNOR S CONFERENCE ON AGING AND DISABILITY
T1: RESOURCES TO ADDRESS THE NEEDS OF PERSONS WITH DEMENTIA AND THEIR CAREGIVERS 2014 GOVERNOR S CONFERENCE ON AGING AND DISABILITY Melanie Chavin, MNA, MS Alzheimer s Association, Greater Illinois Chapter
More informationPrevention of Development of Tolerance and Dependence to Opiate in Mice by BR-16A (Mentat) A Herbal Psychotropic Preparation
[Indian Journal of Experimental Biology (1992): (30), 885] Prevention of Development of Tolerance and Dependence to Opiate in Mice by BR-16A (Mentat) A Herbal Psychotropic Preparation Kulkarni, S.K. and
More informationProtective Effect of Mentat (BR-16A) A Herbal Preparation, on Alcohol Abstinence-Induced Anxiety and Convulsions
[Indian Journal of Experimental Biology (1993): (31), 435] Protective Effect of Mentat (BR-16A) A Herbal Preparation, on Alcohol Abstinence-Induced Anxiety and Convulsions Kulkarni, S.K. and Anita Verma,
More informationVASILE HEFCO 1*, LUCIAN HRITCU 1, ADRIAN TIRON 1, ANDREEA-IOANA HEFCO 1
THE EFFECTS OF NICOTINIC TREATMENT ON MEMORY AND LEARNING IMPAIRMENT INDUCED BY BLOCKADE OF MUSCARINIC ACETYLCHOLINE RECEPTORS ON PERFORMANCE IN RADIAL ARM-MAZE TASK IN RATS VASILE HEFCO, LUCIAN HRITCU,
More informationProtecting the Aging Brain According to a 2014 AARP study,
b y L i n d a M i l o O h r Protecting the Aging Brain According to a 2014 AARP study, brain health is the second most important component in maintaining a healthy lifestyle, after heart health. As the
More informationMEMORY ENHANCING EFFECTS OF FICUS CARICA LEAVES IN HEXANE EXTRACT ON INTEROCEPTIVE BEHAVIORAL MODELS.
Vol 6, Suppl 3, 2013 ISSN - 0974-2441 Research Article MEMORY ENHANCING EFFECTS OF FICUS CARICA LEAVES IN HEXANE EXTRACT ON INTEROCEPTIVE BEHAVIORAL MODELS. *SAXENA VASUNDHARA, AHMAD HAFSA, GUPTA RAJIV
More informationEpilepsy in dementia. Case 1. Dr. Yotin Chinvarun M..D. Ph.D. 5/25/16. CEP, PMK hospital
Epilepsy in dementia Dr. Yotin Chinvarun M..D. Ph.D. CEP, PMK hospital Case 1 M 90 years old Had a history of tonic of both limbs (Lt > Rt) at the age of 88 years old, eye rolled up, no grunting, lasting
More informationCertificate in the Principles of Dementia Care
CACHE Level 2 Certificate in the Principles of Dementia Care LE EQUALITY AND DIVERSITY ACTIVITIES P INTERACTION M PERSON-CENTRED SA MEDICATION Workbook 1 COMMUNICATION In this section, you will learn about
More informationAAYUSHANTI GENERIC RANGE
AAYUSHANTI GENERIC RANGE Ayurvedic medicines have been tried and tested over centuries and still hold fort even today. A product like Triphala Churna which since centuries is considered one of the best
More informationJournal of Pharma Research
Journal of Pharma Research Research Article Available online through ISSN: 2319-5622 www.jprinfo.com Evaluation of Antiepileptic and Nootropic Activity of Momordica Sahyadrica N. Vanaja*, K. Upendar, CH
More informationPatient education : The Effects of Epilepsy on Memory Function
Patient education : The Effects of Epilepsy on Memory Function Patricia G. Banks, RN, MSNEd, CCRP, VHACM Program Coordinator National office of Neurology Louis Stoke Cleveland VAMC Thursday, June 6, 2013
More informationAnimal Products Notice
Animal Products Notice Labelling Requirements for Exports of Dairy Based Infant Formula Products and Formulated Supplementary Food for Young Children 18 December 2014 An animal products notice issued under
More informationEncouraging effect of Brahmi Ghrita in amnesia
Original Article Encouraging effect of Brahmi Ghrita in amnesia Kapil Deo Yadav, K. R. C. Reddy, Vikas Kumar 1 Departments of Rasa Shastra, Faculty of Ayurveda, Institute of Medical Sciences, 1 Pharmaceutics,
More informationWhat is dementia? What is dementia?
What is dementia? What is dementia? What is dementia? Dementia is an umbrella term for a range of progressive conditions that affect the brain. It has been identified that there are over 200 subtypes of
More informationJapan Journal of Medicine 2018; 1(1): doi: xxx/jjm.104
Jpn J Med 2018,1:1 114 Japan Journal of Medicine 2018; 1(1): 114-121. doi: xxx/jjm.104 Mini Review Therapeutic Thematic Arts Programming (TTAP Method ) Meditation Mindfulness: How Meditation Can Enhance
More informationMemree. Supports Cognitive Function and Stress Reduction. Memree. Nutrition
Nutrition Memree Supports Cognitive Function and Stress Reduction Memree for Human Nutrition English Memree Memree contains high-quality soy phosphatidylserine and is a trademark of Lonza Ltd, Switzerland.
More informationPh D THESIS ABSTRACT
ALEXANDRU IOAN CUZA UNIVERSITY IAŞI FACULTY OF BIOLOGY THE STUDY OF CHANGES FOR SEVERAL BIOCHEMICAL PARAMETERS OF OXIDATIVE STRESS IN ANIMAL MODELS FOR NEUROPSYCHIATRIC DISORDERS Ph D THESIS ABSTRACT Scientific
More informationThe Disease To Please Curing The People Pleasing Syndrome
The Disease To Please Curing The People Pleasing Syndrome We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer,
More informationClinically Proven & Award Winning World s Best Ashwagandha
Clinically Proven & Award Winning World s Best Ashwagandha STRESS RELIEF BRAIN HEALTH MUSCLE STRENGTH ENDURANCE SLEEP SEXUAL HEALTH MALE TESTOSTERONE WEIGHT MANAGEMENT KSM-66 Ashwagandha for a healthy
More informationCognitive Impairment - Parkinson's Disease Foundation (PDF)
Page 1 of 8 Cognitive Impairment Another troublesome symptom of Parkinson s is mild cognitive impairment. Many people with Parkinson s are surprised to find that they feel distracted or disorganized, or
More informationSECTION 1: as each other, or as me. THE BRAIN AND DEMENTIA. C. Boden *
I read all the available books by other [people with] Alzheimer s disease but they never had quite the same problems as each other, or as me. I t s not like other diseases, where there is a standard set
More informationWEBINAR SERIES: AGING IN INDIVIDUALS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES
WEBINAR SERIES: AGING IN INDIVIDUALS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES 1 CMS Medicare-Medicaid Coordination Office (MMCO) Established by Section 2602 of the Affordable Care Act Purpose:
More informationLearning Outcomes. To have a clear understanding of the term dementia, and current facts and statistics relating to dementia.
Learning Outcomes To have a clear understanding of the term dementia, and current facts and statistics relating to dementia. To be familiar with some of the common types of dementia. To understand what
More informationAlzheimer s disease 10 warning signs
Alzheimer s disease 10 warning signs Alzheimer s disease is a progressive, degenerative disease of the brain. Symptoms include loss of memory, difficulty with day-to-day tasks and changes in mood and behaviour.
More informationNCFE Level 2 Certificate in The Principles of Dementia Care
The Principles of Dementia Care S A M P LE NCFE Level 2 Certificate in The Principles of Dementia Care Part A 1 These learning resources and assessment questions have been approved and endorsed by ncfe
More informationFACILITATOR TRAINING. TO REGISTER See pages 2-7 for more information and to register
FACILITATOR TRAINING DATES & LOCATIONS Wednesday, September 14, 2016 Chicago, IL Wednesday, November 9, 2016 Springfield, IL Wednesday, November 16, 2016 Chicago, IL* Wednesday, March 15, 2017 Chicago,
More informationScience & Technologies EFFECTS OF CHOLINESTERASE INHIBITORS TACRINE AND METRIFONATE ON EXPLORATORY ACTIVITY IN RATS WITH INDUCED HYPOXIA
EFFECTS OF CHOLINESTERASE INHIBITORS TACRINE AND METRIFONATE ON EXPLORATORY ACTIVITY IN RATS WITH INDUCED HYPOXIA Darinka Dimitrova, Damianka Getova Medical University Plovdiv, Medical Faculty, 2 Plovdiv,
More informationDementia is an overall term for a set of symptoms that is caused by disorders affecting the brain.
Vascular Dementia Vascular Dementia Other Dementias This information sheet provides an overview of a type of dementia known as vascular dementia. In this information sheet you will find: An overview of
More informationEFFECT OF CONVULVULUS PLURICAULIS CHOISY. ON LEARNING BEHAVIOUR AND MEMORY ENHANCEMENT ACTIVITY IN RODENTS
EFFECT OF CONVULVULUS PLURICAULIS CHOISY. ON LEARNING BEHAVIOUR AND MEMORY ENHANCEMENT ACTIVITY IN RODENTS ALOK NAHATA* AND V.K. DIXIT Natural Product Research Laboratory, Department of Pharmaceutical
More informationThe present investigation aims to investigate the effect of different doses of ethanolic extract of pods of Moringa oleifera
ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com EFFECT OF ETHANOLIC EXTRACT OF MORINGA OLEIFERALAM PODS ON LEARNING AND MEMORY IN STREPTOZOTOCIN INDUCED DIABETIC
More informationEffect of a Composite Indian Herbal Preparation, CIHP (III) on Avoidance Learning during Endurance Performance of Rats
[Indian Journal of Experimental Biology (1995): (33), August, 580-584] Effect of a Composite Indian Herbal Preparation, CIHP (III) on Avoidance Learning during Endurance Performance of Rats Bhardwaj, S.K.
More informationCancer Screening Programmes BREAST SCREENING. OVER 70? You are still entitled to breast screening
Cancer Screening Programmes BREAST SCREENING OVER 70? You are still entitled to breast screening Because we do not automatically invite women aged over 70 for breast screening, many believe they are not
More informationCould it be dementia?
Could it be dementia? Contents Could it be dementia? p1 What can affect memory or thinking skills? p1 Physical Health p1 Mental Health p1 Sensory loss p2 Mild cognitive impairment p2 What is dementia?
More informationS-Amlodipine. Dr P Bhandari, MD Director Medical Emcure Pharmaceuticals Ltd.
S-Amlodipine IN HYPERTENSION Dr P Bhandari, MD Director Medical Pharmaceuticals Ltd. www.emcure.co.in www.chiralemcure.com www.emcureadisinfo.com www.emcureusa.com CCB: Place in Therapy The five main classes
More informationResistAid Supports Natural Immune Function
Nutrition English / EU version ResistAid Supports Natural Immune Function ResistAid for Human Nutrition Information for Professionals What Is ResistAid? ResistAid is a proprietary natural immune support
More informationInternational Journal of Pharma and Bio Sciences
Research Article Pharmacognosy International Journal of Pharma and Bio Sciences ISSN 0975-6299 HEPATOPROTECTIVE ACTIVITY OF SEMECARPUS ANACARDIUM FRUIT EXTRACTS AGAINST CARBON TETRACHLORIDE INDUCED HEPATOTOXICITY
More informationClinically Proven & Award Winning
Clinically Proven & Award Winning " World s Best Ashwagandha " STRESS RELIEF BRAIN HEALTH MUSCLE STRENGTH ENDURANCE SLEEP SEXUAL HEALTH MALE TESTOSTERONE WEIGHT MANAGEMENT KSM-66 Ashwagandha for a healthy
More information5.3 AZINPHOS METHYL (002)
5.3 AZINPHOS METHYL (002) TOXICOLOGY Azinphos-methyl is the ISO approved common name for S-3,4-dihydro-4-oxo-1,2,3-benzotriazin-3- ylmethyl O,O-dimethyl phosphorodithioate (IUPAC) or O,O-dimethyl S-[(4-oxo-1,2,3-benzotriazin-
More information4/11/2017. The impact of Alzheimer s disease. Typical changes. The impact of Alzheimer s disease. Problematic changes. Problematic changes
The impact of Alzheimer s disease Ron Petersen, MD, PhD, is Director of the Mayo Alzheimer's Disease Research Center. 2 The impact of Alzheimer s disease Typical changes Typical age-related changes involve:
More informationTHE OPTICAL SOCIETY ONLINE JOURNALS SINGLE SITE LICENSE AGREEMENT
THE OPTICAL SOCIETY ONLINE JOURNALS SINGLE SITE LICENSE AGREEMENT BY THIS AGREEMENT between The Optical Society ( OSA ) and the named below ( Licensee ), OSA grants to Licensee access to the OSA online
More informationAdaptive Design in CIAS
Adaptive Design in CIAS or If you don t know where you re going, any road will get you there Michael Sand, PhD, MPH Senior Clinical Program Leader, CNS Boehringer Ingelheim Disclosures I m an employee
More informationResearch Fellowship Proposal
Research Fellowship APPLICATION FORM Reference number ARUK-RF2018B-012 Applicant Prof Research Team Organisation Alzheimer's Research UK Grant Title Research Fellowship Proposal Grant Duration 36 Grant
More information